Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 4/9/16  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Martin J. Landray

Wrong Dr. Martin J. Landray?

Professor of Medicine and Epidemi...

Phone: +44 **********  
University of Oxford
12 Mansfield Road
Oxford , Oxfordshire OX1 3TA
United Kingdom

Company Description: The University of Oxford offers one of the finest programmes of short courses for professionals in the global electronics and telecoms industries. We offer courses...   more

Employment History

  • Co-Principal Investigator
    Oxford University

Board Memberships and Affiliations


  • MD
    University of Oxford
70 Total References
Web References
Opposing were Martin ... [cached]
Opposing were Martin Landray, professor of medicine and epidemiology, at the University of Oxford, in the U.K., and Bettina Ryll, the Uppsala, Sweden-based founder of Melanoma Patient Network Europe.
Landray countered that the current problems arise from an absence of or inadequate engineering. He cast poor interpretation and misapplication of regulations and an overly cautious approach to technology as the "enemies of innovation. He argued for a quality-by-design approach to clinical development, which builds on a culture of critical thinking, focusing efforts on essential activities and focus on errors that matter, while building broad stakeholder engagement. All of these are principles of engineering design, he said. "Our failure has been to apply those principles closely," he said. "It's not overengineering is the problem - it's forgetting to engineer is the problem."
He defended regulators, who have made valuable inputs into new development approaches, such as quality by design, risk-based management and risk-proportionate studies "All these things come out of working with regulators," he said.
"We agree that trials are too expensive, too slow, highly wasteful and do not address the questions we want," Landray said. "That's not overengineering - that's insanity."
By the close of the debate, Landray and Ryll had managed to shift the audience significantly.
Research based on small numbers of ... [cached]
Research based on small numbers of patients contains too many errors, particularly when it comes to analyzing the risk factors for diseases."We crave information about large numbers of people over long periods," says Martin Landray, professor of medicine and epidemiology at the University of Oxford.
Prof Martin Landray, ... [cached]
Prof Martin Landray, professor of medicine and epidemiology at the University of Oxford, says the challenge is "how to make sense of it".
He is helping to analyse data from the UK Biobank, a project which started in 2006 and which has recruited half a million people aged 40 to 69 from across the country.
Prof Landray says: "You can't just sit a radiologist down in front of thousands of MRI scans to analyse.
"They now have the opportunity to ask those questions in rapid time," Prof Landray says.
"We have been very interested in ... [cached]
"We have been very interested in the whole area of sensors and mobile health, using technology to capture information that might not otherwise be captured using traditional routes, and using that both to inform discovery - so, associations between behaviour or genetics and disease - and to provide new ways of improving health", says Professor Martin Landray, a cardiologist and researcher at the University of Oxford, who is involved in the project.
"Patients come to me each week describing their palpitations", says Professor Landray.
NIHR Evaluation, Trials and Studies | Our people [cached]
Dr Martin Landray Professor of Medicine and Epidemiology, University of Oxford
Other People with the name "Landray":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.